This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Meir Shalit, MD; Moshe Y. Flugelman, MD; Noam Harats, MD; Eithan Galun, MD; Zvi Ackerman, MD; Juri Kopolovic, MD; Marcel Eliakim, MD

Arch Intern Med. 1985;145(11):2051-2052.

Abstract
• Four patients developed nonthrombocytopenic purpura two to three weeks after initiation of quinidine therapy. The skin lesions disappeared and did not recur after cessation of quinidine therapy. Histologic examination revealed leukocytoclastic vasculitis with deposition of C3, IgA, and/or IgM in the small dermal vessels. Since quinidine purpura is usually associated with thrombocytopenia, the possibility of leukocytoclastic vasculitis as an additional cause of purpura is stressed.

(Arch Intern Med 1985;145:2051-2052)

Author Affiliations
From the Departments of Medicine A (Drs Shalit, Flugelman, Harats, Galun, Ackerman, and Eliakim) and Pathology (Dr Kopolovic), Hadassah University Hospital, Jerusalem.

Footnotes
Accepted for publication Feb 8, 1985.

Reprint requests to Department of Medicine A, Hadassah University Hospital, PO Box 12000, Jerusalem 91120, Israel (Dr Shalit).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quinidine
Grace and Camm
NEJM 1998;338:35-45.
FULL TEXT  

Quinidine and Rheumatic Syndromes
Schmid
ANN INTERN MED 1988;109:247-249.
ABSTRACT  

Two Distinct Quinidine-Induced Rheumatic Syndromes
COHEN et al.
ANN INTERN MED 1988;108:369-371.
ABSTRACT